Click for best price
Postpemic Era Remote Clinical Trials Market Size, Share 2022
Summary
The global and Chinese economies were hit hard in 2020, and the global GDP grew by 5.9% in 2021. Although the global growth prospects improved and there was a V-shaped rebound, this does not mean that the economy has really recovered to the level before the epidemic. The vast majority of countries are still in the stage of recovery after heavy damage and are far from achieving real recovery.
2022 is a year of continuous recovery. Global supply chain disturbance, geopolitical tension, energy price fluctuation, local labor shortage and rising raw material prices will affect the resilience of economic recovery. The International Monetary Fund (IMF) predicts that the world economy will grow by 4.4% in 2022, of which the U.S. economy will grow by about 4%. Driven by China and India, Asia is expected to become the fastest growing region in the world in 2022. However, China's economic growth has slowed down. The 2022 government work report shows that the expected target of economic growth is set at about 5.5%.
According to research, China has set a growth rate of about 5.5%, which not only focuses on the speed of economic growth, but also anchors the quality of economic development. Scientific and technological innovation, economic and social digitization and green development will be the long-term goals of China's economic development. It is expected that in 2022, major economies such as the United States, Europe and China will introduce more favorable policies to drive the development of switching power supply industry.
Global Remote Clinical Trials Market Segment Research Report 2022?, which aims to sort out the development status and trends of the Remote Clinical Trials industry at home and abroad, estimate the overall market scale of the Remote Clinical Trials industry and the market share of major countries, Remote Clinical Trials industry, and study and judge the downstream market demand of Remote Clinical Trials through systematic research, Analyze the competition pattern of Remote Clinical Trials, so as to help solve the pain points of various stakeholders in Remote Clinical Trials industry. This industry research report combines desktop research, qualitative interviews with insiders or experts and other methods to strive for the objectivity and integrity of conclusions and data.
Regional Segmentation (Value; Revenue, USD Million, 2018-2028) of Remote Clinical Trials Market by XYZResearch Include
USA
Europe
China
Japan
India
Korea
Southeast Asia
Competitive Analysis; Who are the Major Players in Remote Clinical Trials Market?
Medidata
IQVIA
Labcorp
PRA Health Sciences
Parexel
ICON
Oracle
CRF Health
Clinical Ink
Medable
Science 37
Major Type of Remote Clinical Trials Covered in XYZResearch report:
Interventional
Observational
Expanded Access
Application Segments Covered in XYZResearch Market
Oncology
Cardiovascular
Others
For any other requirements, please feel free to contact us and we will provide you customized report.
| Report Attributes |
Report Details |
| Report Title |
(Post-pandemic Era)-Global Remote Clinical Trials Market Segment Research Report 2022 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
94 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
Table of Contents
Global Remote Clinical Trials Market Segment Research Report 2022
1. Research Scope
2. Market Overview
2.1 Product Introduction, Application, Picture
2.2 Global Remote Clinical Trials Market by Value
2.2.1 Global Remote Clinical Trials Revenue by Type
2.2.2 Global Remote Clinical Trials Market by Value
2.3 Global Remote Clinical Trials Market by Sales
2.3.1 Global Remote Clinical Trials Sales by Type
2.3.2 Global Remote Clinical Trials Market by Sales
3. The Major Driver of Remote Clinical Trials Industry
3.1 Historical & Forecast Global Remote Clinical Trials Sales and Revenue (2018-2028)
3.2 Largest Application for Remote Clinical Trials (2018-2028)
3.3 The Major Downstream Company in China Market 2022
4. Global and Regional Remote Clinical Trials Market
4.1 Regional Market Size in Terms of Sales (2022 & 2028)
4.2 Regional Market Share in Terms of Revenue (2022 & 2028)
4.3 Concentration Ratio (CR5& CR10) of Remote Clinical Trials Market
4.4 Mergers & Acquisitions, Expansion Plans
5. US Remote Clinical Trials Sales (2018-2028)
5.1 Current and Estimated Sales Breakdown by Type (2018-2028)
5.2 Current and Estimated Sales Breakdown by Application (2018-2028)
5.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
5.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
6. Europe Remote Clinical Trials Sales (2018-2028)
6.1 Current and Estimated Sales Breakdown by Type (2018-2028)
6.2 Current and Estimated Sales Breakdown by Application (2018-2028)
6.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
6.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
7. China Remote Clinical Trials Sales (2018-2028)
7.1 Current and Estimated Sales Breakdown by Type (2018-2028)
7.2 Current and Estimated Sales Breakdown by Application (2018-2028)
7.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
7.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
8. Japan Remote Clinical Trials Sales (2018-2028)
8.1 Current and Estimated Sales Breakdown by Type (2018-2028)
8.2 Current and Estimated Sales Breakdown by Application (2018-2028)
8.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
8.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
9. India Remote Clinical Trials Sales (2018-2028)
9.1 Current and Estimated Sales Breakdown by Type (2018-2028)
9.2 Current and Estimated Sales Breakdown by Application (2018-2028)
9.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
9.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
10. Korea Remote Clinical Trials Sales (2018-2028)
10.1 Current and Estimated Sales Breakdown by Type (2018-2028)
10.2 Current and Estimated Sales Breakdown by Application (2018-2028)
10.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
10.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
11. Southeast Asia Remote Clinical Trials Sales (2018-2028)
11.1 Current and Estimated Sales Breakdown by Type (2018-2028)
11.2 Current and Estimated Sales Breakdown by Application (2018-2028)
11.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
11.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
12. South America Remote Clinical Trials Sales (2018-2028)
12.1 Current and Estimated Sales Breakdown by Type (2018-2028)
12.2 Current and Estimated Sales Breakdown by Application (2018-2028)
12.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
12.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
13. Global Remote Clinical Trials Average Price Trend
13.1 Market Price for Each Type of Remote Clinical Trials in US (2018-2022)
13.2 Market Price for Each Type of Remote Clinical Trials in Europe (2018-2022)
13.3 Market Price for Each Type of Remote Clinical Trials in China (2018-2022)
13.4 Market Price for Each Type of Remote Clinical Trials in Japan (2018-2022)
13.5 Market Price for Each Type of Remote Clinical Trials in India (2018-2022)
13.6 Market Price for Each Type of Remote Clinical Trials in Korea (2018-2022)
13.7 Market Price for Each Type of Remote Clinical Trials in Southeast Asia (2018-2022)
13.8 Market Price for Each Type of Remote Clinical Trials in South America (2018-2022)
14. Industrial Chain (Impact of COVID-19)
14.1 Remote Clinical Trials Industrial Chain Analysis
14.2 Downstream
14.3 Impact of COVID-19
14.4 Post-pandemic Era
14.5 Technology Trends of Remote Clinical Trials
15. Remote Clinical Trials Competitive Landscape
15.1 Medidata
15.1.1 Medidata Company Profiles
15.1.2 Medidata Product Introduction
15.1.3 Medidata Remote Clinical Trials Sales, Revenue (2018-2022)
15.1.4 Strategic initiatives
15.2 IQVIA
15.2.1 IQVIA Company Profiles
15.2.2 IQVIA Product Introduction
15.2.3 IQVIA Remote Clinical Trials Sales, Revenue (2018-2022)
15.2.4 Strategic initiatives
15.3 Labcorp
15.3.1 Labcorp Company Profiles
15.3.2 Labcorp Product Introduction
15.3.3 Labcorp Remote Clinical Trials Sales, Revenue (2018-2022)
15.3.4 Strategic initiatives
15.4 PRA Health Sciences
15.4.1 PRA Health Sciences Company Profiles
15.4.2 PRA Health Sciences Product Introduction
15.4.3 PRA Health Sciences Remote Clinical Trials Sales, Revenue (2018-2022)
15.4.4 Strategic initiatives
15.5 Parexel
15.5.1 Parexel Company Profiles
15.5.2 Parexel Product Introduction
15.5.3 Parexel Remote Clinical Trials Sales, Revenue (2018-2022)
15.5.4 Strategic initiatives
15.6 ICON
15.6.1 ICON Company Profiles
15.6.2 ICON Product Introduction
15.6.3 ICON Remote Clinical Trials Sales, Revenue (2018-2022)
15.6.4 Strategic initiatives
15.7 Oracle
15.7.1 Oracle Company Profiles
15.7.2 Oracle Product Introduction
15.7.3 Oracle Remote Clinical Trials Sales, Revenue (2018-2022)
15.7.4 Strategic initiatives
15.8 CRF Health
15.8.1 CRF Health Company Profiles
15.8.2 CRF Health Product Introduction
15.8.3 CRF Health Remote Clinical Trials Sales, Revenue (2018-2022)
15.8.4 Strategic initiatives
15.9 Clinical Ink
15.9.1 Clinical Ink Company Profiles
15.9.2 Clinical Ink Product Introduction
15.9.3 Clinical Ink Remote Clinical Trials Sales, Revenue (2018-2022)
15.9.4 Strategic initiatives
15.10 Medable
15.10.1 Medable Company Profiles
15.10.2 Medable Product Introduction
15.10.3 Medable Remote Clinical Trials Sales, Revenue (2018-2022)
15.10.4 Strategic initiatives
15.11 Science 37
16. Conclusion
17. Methodology and Data Source
LIST OF TABLES & FIGURES
List of Tables and Figures
Figure 1. Total Sales by Application of Remote Clinical Trials Industry (Volume)
Figure 2. Remote Clinical Trials Sales by Regions in 2022
Figure 3. Regional Market Share in Terms of Revenue (2022&2028)
Figure 4. The Top 10 and 5 Players Market Share by Remote Clinical Trials Revenue in 2022
Figure 5. US Remote Clinical Trials Sales (2018-2028)
Figure 6. Sales Breakdown by Type (%)
Figure 7. Sales Breakdown by Type (%)
Figure 8. Sales Breakdown by Application (%)
Figure 9. Revenue Breakdown by Type (%)
Figure 10. Revenue Breakdown by Application (%)
Figure 11. Europe Remote Clinical Trials Sales (2018-2028)
Figure 12. Sales Breakdown by Type (%)
Figure 13. Sales Breakdown by Type (%)
Figure 14. Sales Breakdown by Application (%)
Figure 15. Revenue Breakdown by Type (%)
Figure 16. Revenue Breakdown by Application (%)
Figure 17. China Remote Clinical Trials Sales (2018-2028)
Figure 18. Sales Breakdown by Type (%)
Figure 19. Sales Breakdown by Type (%)
Figure 20. Sales Breakdown by Application (%)
Figure 21. Current and Estimated Revenue Breakdown by Type
Figure 22. Revenue Breakdown by Type (%)
Figure 23. Revenue Breakdown by Application (%)
Figure 24. Japan Remote Clinical Trials Sales (2018-2028)
Figure 25. Sales Breakdown by Type (%)
Figure 26. Sales Breakdown by Type (%)
Figure 27. Sales Breakdown by Application (%)
Figure 28. Revenue Breakdown by Type (%)
Figure 29. Revenue Breakdown by Application (%)
Figure 30. India Remote Clinical Trials Sales (2018-2028)
Figure 31. Sales Breakdown by Type (%)
Figure 32. Sales Breakdown by Type (%)
Figure 33. Sales Breakdown by Application (%)
Figure 34. Revenue Breakdown by Type (%)
Figure 35. Revenue Breakdown by Application (%)
Figure 36. Korea Remote Clinical Trials Sales (2018-2028)
Figure 37. Sales Breakdown by Type (%)
Figure 38. Sales Breakdown by Type (%)
Figure 39. Sales Breakdown by Application (%)
Figure 40. Revenue Breakdown by Type (%)
Figure 41. Revenue Breakdown by Application (%)
Figure 42. Southeast Asia Remote Clinical Trials Sales (2018-2028)
Figure 43. Current and Estimated Sales Breakdown by Type (2018-2028)
Figure 44. Sales Breakdown by Type (%)
Figure 45. Sales Breakdown by Type (%)
Figure 46. Revenue Breakdown by Type (%)
Figure 47. Revenue Breakdown by Application (%)
Figure 48. Industrial Chain
Table 1. Top Manufacturers and Market Segmentation
Table 2. Product Introduction, Application, Picture
Table 3. Remote Clinical Trials Revenue, by Type (Million USD) (2018-2028)
Table 4. Remote Clinical Trials Sales, by Type (K Unit) (2018-2028)
Table 5. Remote Clinical Trials Sales (K Unit) by Application (2018-2028)
Table 6. Remote Clinical Trials Sales (Million USD) by Application (2018-2028)
Table 7. The Major Downstream Company in China
Table 8. Regional Market Share in Terms of Sales (2022)
Table 9. Regional Market Share in Terms of Revenue (2022&2028)
Table 10. Ranking of Global Top Remote Clinical Trials Companies by Revenue, Concentration Ratio in 2022
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. US Remote Clinical Trials Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 13. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 14. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 15. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 16. Current and Estimated Revenue Breakdown by Type
Table 17. Current and Estimated Revenue Breakdown by Application
Table 18. Europe Remote Clinical Trials Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 19. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 20. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 21. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 22. Current and Estimated Revenue Breakdown by Type
Table 23. Current and Estimated Revenue Breakdown by Application
Table 24. China Remote Clinical Trials Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 25. Table Current and Estimated Sales Breakdown by Type
Table 26. Current and Estimated Sales Breakdown by Type
Table 27. Current and Estimated Sales Breakdown by Application
Table 28. Current and Estimated Revenue Breakdown by Application
Table 29. Japan Remote Clinical Trials Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 30. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 31. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 32. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 33. Current and Estimated Revenue Breakdown by Type
Table 34. Current and Estimated Revenue Breakdown by Application
Table 35. India Remote Clinical Trials Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 36. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 37. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 38. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 39. Current and Estimated Revenue Breakdown by Type
Table 40. Current and Estimated Revenue Breakdown by Application
Table 41. Korea Remote Clinical Trials Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 42. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 43. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 44. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 45. Current and Estimated Revenue Breakdown by Type
Table 46. Current and Estimated Revenue Breakdown by Application
Table 47. Southeast Asia Remote Clinical Trials Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 48. Table Current and Estimated Sales Breakdown by Type (2018-2028)
Table 49. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 50. Current and Estimated Revenue Breakdown by Type
Table 51. Current and Estimated Revenue Breakdown by Application
Table 52. Market Price (USD/Unit) for Each Type of Remote Clinical Trials in US (2018-2022)
Table 53. Market Price (USD/Unit) for Each Type of Remote Clinical Trials in Europe (2018-2022)
Table 54. Market Price (USD/Unit) for Each Type of Remote Clinical Trials in China (2018-2022)
Table 55. Market Price (USD/Unit) for Each Type of Remote Clinical Trials in Japan (2018-2022)
Table 56. Market Price (USD/Unit) for Each Type of Remote Clinical Trials in India (2018-2022)
Table 57. Market Price (USD/Unit) for Each Type of Remote Clinical Trials in Korea (2018-2022)
Table 58. Market Price (USD/Unit) for Each Type of Remote Clinical Trials in Southeast Asia (2018-2022)
Table 59. Key Downstream Customer in Each Application Field
Table 60. Medidata Profiles
Table 61. Medidata Remote Clinical Trials Product Introduction
Table 62. Medidata Remote Clinical Trials Sales (Unit), Revenue (Million USD) (2018-2022)
Table 63. Medidata Strategic initiatives
Table 64. IQVIA Profiles
Table 65. IQVIA Remote Clinical Trials Product Introduction
Table 66. IQVIA Remote Clinical Trials Sales (Unit), Revenue (Million USD) (2018-2022)
Table 67. IQVIA Strategic initiatives
Table 68. Labcorp Profiles
Table 69. Labcorp Remote Clinical Trials Product Introduction
Table 70. Labcorp Remote Clinical Trials Sales (Unit), Revenue (Million USD) (2018-2022)
Table 71. Labcorp Strategic initiatives
Table 72. PRA Health Sciences Profiles
Table 73. PRA Health Sciences Remote Clinical Trials Product Introduction
Table 74. PRA Health Sciences Remote Clinical Trials Sales (Unit), Revenue (Million USD) (2018-2022)
Table 75. PRA Health Sciences Strategic initiatives
Table 76. Parexel Profiles
Table 77. Parexel Remote Clinical Trials Product Introduction
Table 78. Parexel Remote Clinical Trials Sales (Unit), Revenue (Million USD) (2018-2022)
Table 79. Parexel Strategic initiatives
Table 80. ICON Profiles
Table 81. ICON Remote Clinical Trials Product Introduction
Table 82. ICON Remote Clinical Trials Sales (Unit), Revenue (Million USD) (2018-2022)
Table 83. ICON Strategic initiatives
Table 84. Oracle Profiles
Table 85. Oracle Remote Clinical Trials Product Introduction
Table 86. Oracle Remote Clinical Trials Sales (Unit), Revenue (Million USD) (2018-2022)
Table 87. Oracle Strategic initiatives
Table 88. CRF Health Profiles
Table 89. CRF Health Remote Clinical Trials Product Introduction
Table 90. CRF Health Remote Clinical Trials Sales (Unit), Revenue (Million USD) (2018-2022)
Table 91. CRF Health Strategic initiatives
Table 92. Clinical Ink Profiles
Table 93. Clinical Ink Remote Clinical Trials Product Introduction
Table 94. Clinical Ink Remote Clinical Trials Sales (Unit), Revenue (Million USD) (2018-2022)
Table 95. Clinical Ink Strategic initiatives
Table 97. Medable Profiles
Table 98. Medable Remote Clinical Trials Product Introduction
Table 99. Medable Remote Clinical Trials Sales (Unit), Revenue (Million USD) (2018-2022)
Table 100. Medable Strategic initiatives
Table 101. Science 37 Profiles
Table 102. Science 37 Remote Clinical Trials Product Introduction
Table 103. Science 37 Remote Clinical Trials Sales (Unit), Revenue (Million USD) (2018-2022)
Table 104. Science 37 Strategic initiatives
